Comprehensive analysis of organophosphorus flame retardant-induced mitochondrial abnormalities: Potential role in

Yifei Le1, Haiping Shen1, Zhen Yang1

  • 1College of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.

Insights

Organophosphorus flame retardants (OPFRs) can disrupt metabolism by affecting mitochondria. Aryl-OPFRs and TDCPP are potent inducers of lipid accumulation and mitochondrial dysfunction, highlighting their metabolic disruption capacity.

Area of Science:

  • Environmental Toxicology
  • Mitochondrial Biology
  • Metabolic Disruptions

Background:

  • Organophosphorus flame retardants (OPFRs) are emerging endocrine disruptors linked to metabolic disturbances.
  • Mitochondrial dysfunction is a key indicator for evaluating chemical-mediated metabolic disruption.
  • A comprehensive understanding of the correlation between OPFRs and mitochondrial dysfunction remains incomplete.

Purpose of the Study:

  • To investigate the relationship between OPFR exposure and mitochondrial abnormalities.
  • To assess the metabolic disruption potential of different OPFRs, including aryl and chlorinated compounds.
  • To identify specific OPFRs that are potent inducers of lipid accumulation and mitochondrial dysfunction.

Main Methods:

  • Hepatocytes were treated with two aryl-OPFRs (TCP, TPhP) and three chlorinated-OPFRs (TDCPP, TCPP, TCEP).
  • Morphological and mitochondrial dysfunction markers were analyzed, including lipid accumulation, mitochondrial network, ATP levels, ROS production, and membrane potential.
  • Correlation analyses were performed to link lipid accumulation capacity with mitochondrial dysfunction markers.

Main Results:

  • Aryl-OPFRs (TCP, TPhP) and TDCPP induced significant intracellular lipid accumulation at non-cytotoxic concentrations.
  • All tested OPFRs reduced mitochondrial network numbers, increased mitochondrial area, and altered ATP distribution.
  • Mitochondrial respiratory rate showed the highest correlation with lipid accumulation capacity, identifying TPhP, TCP, and TDCPP as potent inducers.

Conclusions:

  • Aryl-OPFRs demonstrate greater potency in metabolic disruption compared to other OPFR esters examined.
  • Mitochondrial dysfunction, particularly impaired respiratory rate, is a strong indicator of OPFR-induced metabolic disruption.
  • Further investigation into chemicals affecting mitochondrial functions is crucial for understanding metabolic disruption.